Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy
Office of Infectious Diseases · The University of Texas Health Science Center at Houston · +2 more institutions
Indexed incrossref
Abstract
Background
There is little systematic information regarding the immune reconstitution inflammatory syndrome (IRIS).
Objective
To determine the incidence, risk factors, and long-term outcome of IRIS in HIV-infected patients receiving highly active antiretroviral therapy (HAART) who were coinfected with one of three common opportunistic pathogens.
Citation impact
634
total citations
- FWCI
- 47.16
- Percentile
- 100%
- References
- 34
Citations per year
Authors
7- SASamuel A. Shelburne
Office of Infectious Diseases
- FVFehmida Visnegarwala
Office of Infectious Diseases, The University of Texas Health Science Center at Houston
- JDJorge Darcourt
Baylor College of Medicine
- EAEdward A. Graviss
The University of Texas Health Science Center at Houston
- TPThomas P. Giordano
Office of Infectious Diseases, The University of Texas Health Science Center at Houston
Topics & keywords
Topics
Keywords
- Immune reconstitution inflammatory syndrome
- Antiretroviral therapy
- Incidence (geometry)
- Medicine
- Immune system
- Immunology
- Risk factor
- Immunopathology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.